Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
202.5 USD | +0.23% | +6.27% | -21.76% |
02:57pm | Goldman Sachs Adjusts Biogen Price Target to $340 From $393 | MT |
02:39pm | Canaccord Genuity Adjusts Price Target on Biogen to $308 From $305 | MT |
Financials (USD)
Sales 2024 * | 9.52B | Sales 2025 * | 9.57B | Capitalization | 29.41B |
---|---|---|---|---|---|
Net income 2024 * | 1.85B | Net income 2025 * | 2.25B | EV / Sales 2024 * | 3.45 x |
Net Debt 2024 * | 3.38B | Net Debt 2025 * | 349M | EV / Sales 2025 * | 3.11 x |
P/E ratio 2024 * |
15.5
x | P/E ratio 2025 * |
13.2
x | Employees | 7,570 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.34% |
Latest transcript on Biogen Inc.
1 day | -1.30% | ||
1 week | +4.68% | ||
Current month | -7.51% | ||
1 month | -7.96% | ||
3 months | -19.00% | ||
6 months | -19.16% | ||
Current year | -22.93% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 22-11-13 | |
Director of Finance/CFO | 60 | 20-08-14 | |
Nicole Murphy
COO | Chief Operating Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 09-12-31 |
William Hawkins
BRD | Director/Board Member | 70 | 19-06-18 |
Caroline Dorsa
CHM | Chairman | 64 | 10-01-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.30% | 1 M€ | 0.00% | - | |
3.92% | 0 M€ | 0.00% | - | |
3.75% | 0 M€ | 0.00% | - | |
2.39% | 14,021 M€ | +3.35% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 202.5 | +0.23% | 1 590 136 |
24-04-24 | 202 | +4.56% | 3,265,676 |
24-04-23 | 193.2 | -0.48% | 1,461,694 |
24-04-22 | 194.1 | -0.14% | 1,119,536 |
24-04-19 | 194.4 | +2.03% | 1,599,713 |
Delayed Quote Nasdaq, April 25, 2024 at 12:10 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.93% | 29.36B | |
-2.86% | 87.31B | |
+2.63% | 40.86B | |
+58.56% | 24.49B | |
-15.21% | 17.31B | |
-19.02% | 11.62B | |
-15.61% | 11.31B | |
-44.02% | 11.26B | |
+5.17% | 8.31B | |
-9.82% | 7.9B |
- Stock Market
- Equities
- BIIB Stock